647 related articles for article (PubMed ID: 26233910)
1. Bile Acid Metabolism and Signaling in Cholestasis, Inflammation, and Cancer.
Li T; Apte U
Adv Pharmacol; 2015; 74():263-302. PubMed ID: 26233910
[TBL] [Abstract][Full Text] [Related]
2. Bile salts and cholestasis.
Maillette de Buy Wenniger L; Beuers U
Dig Liver Dis; 2010 Jun; 42(6):409-18. PubMed ID: 20434968
[TBL] [Abstract][Full Text] [Related]
3. Bile acid metabolism and signaling.
Chiang JY
Compr Physiol; 2013 Jul; 3(3):1191-212. PubMed ID: 23897684
[TBL] [Abstract][Full Text] [Related]
4. Role of farnesoid X receptor in cholestasis.
Yuan ZQ; Li KW
J Dig Dis; 2016 Aug; 17(8):501-509. PubMed ID: 27383832
[TBL] [Abstract][Full Text] [Related]
5. Bile Acids in Cholestasis and its Treatment.
Arab JP; Cabrera D; Arrese M
Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):s53-s57. PubMed ID: 29080340
[TBL] [Abstract][Full Text] [Related]
6. Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury.
Stedman CA; Liddle C; Coulter SA; Sonoda J; Alvarez JG; Moore DD; Evans RM; Downes M
Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2063-8. PubMed ID: 15684063
[TBL] [Abstract][Full Text] [Related]
7. Nuclear receptors as therapeutic targets in cholestatic liver diseases.
Zollner G; Trauner M
Br J Pharmacol; 2009 Jan; 156(1):7-27. PubMed ID: 19133988
[TBL] [Abstract][Full Text] [Related]
8. Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations.
Zollner G; Marschall HU; Wagner M; Trauner M
Mol Pharm; 2006; 3(3):231-51. PubMed ID: 16749856
[TBL] [Abstract][Full Text] [Related]
9. Bile acid signaling in metabolic disease and drug therapy.
Li T; Chiang JY
Pharmacol Rev; 2014 Oct; 66(4):948-83. PubMed ID: 25073467
[TBL] [Abstract][Full Text] [Related]
10. Bile Acids and GPBAR-1: Dynamic Interaction Involving Genes, Environment and Gut Microbiome.
Portincasa P; Di Ciaula A; Garruti G; Vacca M; De Angelis M; Wang DQ
Nutrients; 2020 Nov; 12(12):. PubMed ID: 33266235
[TBL] [Abstract][Full Text] [Related]
11. Coordinate regulation of hepatic bile acid oxidation and conjugation by nuclear receptors.
Trottier J; Milkiewicz P; Kaeding J; Verreault M; Barbier O
Mol Pharm; 2006; 3(3):212-22. PubMed ID: 16749854
[TBL] [Abstract][Full Text] [Related]
12. Bile Acid Metabolism in Liver Pathobiology.
Chiang JYL; Ferrell JM
Gene Expr; 2018 May; 18(2):71-87. PubMed ID: 29325602
[TBL] [Abstract][Full Text] [Related]
13. Nuclear receptors. I. Nuclear receptors and bile acid homeostasis.
Goodwin B; Kliewer SA
Am J Physiol Gastrointest Liver Physiol; 2002 Jun; 282(6):G926-31. PubMed ID: 12016116
[TBL] [Abstract][Full Text] [Related]
14. Formononetin ameliorates cholestasis by regulating hepatic SIRT1 and PPARĪ±.
Yang S; Wei L; Xia R; Liu L; Chen Y; Zhang W; Li Q; Feng K; Yu M; Zhang W; Qu J; Xu S; Mao J; Fan G; Ma C
Biochem Biophys Res Commun; 2019 May; 512(4):770-778. PubMed ID: 30928103
[TBL] [Abstract][Full Text] [Related]
15. Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis.
Meng Q; Chen XL; Wang CY; Liu Q; Sun HJ; Sun PY; Huo XK; Liu ZH; Yao JH; Liu KX
Toxicol Appl Pharmacol; 2015 Mar; 283(3):178-86. PubMed ID: 25655198
[TBL] [Abstract][Full Text] [Related]
16. Nuclear receptors in acute and chronic cholestasis.
Gonzalez-Sanchez E; Firrincieli D; Housset C; Chignard N
Dig Dis; 2015; 33(3):357-66. PubMed ID: 26045270
[TBL] [Abstract][Full Text] [Related]
17. Benefit of farnesoid X receptor inhibition in obstructive cholestasis.
Stedman C; Liddle C; Coulter S; Sonoda J; Alvarez JG; Evans RM; Downes M
Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11323-8. PubMed ID: 16844773
[TBL] [Abstract][Full Text] [Related]
18. Arbutin Alleviates the Liver Injury of
Wu P; Qiao L; Yu H; Ming H; Liu C; Wu W; Li B
Front Cell Dev Biol; 2021; 9():758632. PubMed ID: 34926449
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of bile acid mediated inflammation in the liver.
Li M; Cai SY; Boyer JL
Mol Aspects Med; 2017 Aug; 56():45-53. PubMed ID: 28606651
[TBL] [Abstract][Full Text] [Related]
20. Bile acids and their receptors: modulators and therapeutic targets in liver inflammation.
Bertolini A; Fiorotto R; Strazzabosco M
Semin Immunopathol; 2022 Jul; 44(4):547-564. PubMed ID: 35415765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]